RADIANCE is a renowned brand that specializes in the development of innovative solutions for the treatment of hypertension. With over 1 billion people affected by hypertension worldwide, RADIANCE is dedicated to providing cutting-edge products and services to address this global health issue. One of their remarkable advancements is the Paradise™ Renal Denervation System, a unique therapeutic non-focused ultrasound technology designed to perform renal denervation.

This potential new approach offers a promising alternative for the treatment of hypertension. RADIANCE has launched the RADIANCE Global Program, a groundbreaking international initiative aimed at exploring the benefits of renal denervation in hypertension. This program includes the RADIANCE-II trial, which is currently enrolling patients to study the safety and effectiveness of the Paradise System in reducing blood pressure without the need for antihypertensive medications.

Additionally, the RADIANCE-HTN clinical trial has delivered impressive results, demonstrating the positive impact of the Paradise System in patients with true treatment-resistant hypertension. To learn more about the clinical results, visit their Clinical Results Page. RADIANCE is driven by a commitment to medical education and clinical trials, with a strong focus on bringing innovative solutions to healthcare professionals and patients.

With their cutting-edge technology, strong clinical evidence, and global presence, RADIANCE continues to revolutionize the treatment of hypertension and improve the lives of millions worldwide